Pharmacogenomics allows us to identify sources of an individual’s profile of drug response and predict the best possible treatment option for this individual. The use of genomic information has opened new possibilities in drug discovery and development.
The Genomics and Targeted Therapy Group, in FDA's Office of Clinical Pharmacology, works to advance the application of Genomics in the discovery, development, regulation, and use of medication.
Regulatory and Scientific Information
Table of Pharmacogenomic Biomarkers in Drug Labeling Genomics Guidances, Concept Papers, and MaPPs Voluntary Exploratory Data Submissions (VXDS)[ARCHIVED]
[formerly Voluntary Genomic Data Submission (VGDS)]
Genomics: Frequently Asked Questions